COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
75.56 EUR
+0.1 (+0.13%)
Taking everything into account, CBHD scores 6 out of 10 in our fundamental rating. CBHD was compared to 68 industry peers in the Health Care Equipment & Supplies industry. While CBHD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate. CBHD also has an excellent dividend rating. These ratings would make CBHD suitable for dividend investing!
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
CBHD had a positive operating cash flow in the past year.
In the past 5 years CBHD has always been profitable.
In the past 5 years CBHD always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 7.52%, CBHD belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
Looking at the Return On Equity, with a value of 22.55%, CBHD belongs to the top of the industry, outperforming 91.18% of the companies in the same industry.
With an excellent Return On Invested Capital value of 12.65%, CBHD belongs to the best of the industry, outperforming 92.65% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is above the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD's Profit Margin of 13.04% is fine compared to the rest of the industry. CBHD outperforms 76.47% of its industry peers.
CBHD's Profit Margin has declined in the last couple of years.
CBHD's Operating Margin of 27.52% is amongst the best of the industry. CBHD outperforms 94.12% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
CBHD has a Gross Margin of 67.97%. This is in the better half of the industry: CBHD outperforms 76.47% of its industry peers.
In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
CBHD has about the same amout of shares outstanding than it did 1 year ago.
CBHD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBHD has an improved debt to assets ratio.
2.2 Solvency
CBHD has an Altman-Z score of 3.92. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CBHD (3.92) is better than 70.59% of its industry peers.
CBHD has a debt to FCF ratio of 4.34. This is a neutral value as CBHD would need 4.34 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.34, CBHD is in line with its industry, outperforming 57.35% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
CBHD's Debt to Equity ratio of 1.24 is on the low side compared to the rest of the industry. CBHD is outperformed by 80.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.92 |
ROIC/WACC2.28
WACC5.55%
2.3 Liquidity
A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
CBHD's Current ratio of 1.61 is in line compared to the rest of the industry. CBHD outperforms 47.06% of its industry peers.
A Quick Ratio of 1.00 indicates that CBHD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, CBHD is in line with its industry, outperforming 41.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -20.93% in the last year.
The Earnings Per Share has been decreasing by -2.02% on average over the past years.
CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.49% on average per year.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.23% on average per year.
The Revenue is expected to grow by 6.95% on average over the next years.
EPS Next Y46.79%
EPS Next 2Y27.16%
EPS Next 3Y21.25%
EPS Next 5Y16.23%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 31.75, which means the current valuation is very expensive for CBHD.
The rest of the industry has a similar Price/Earnings ratio as CBHD.
Compared to an average S&P500 Price/Earnings ratio of 27.25, CBHD is valued at the same level.
A Price/Forward Earnings ratio of 21.66 indicates a rather expensive valuation of CBHD.
The rest of the industry has a similar Price/Forward Earnings ratio as CBHD.
When comparing the Price/Forward Earnings ratio of CBHD to the average of the S&P500 Index (23.98), we can say CBHD is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.75 | ||
| Fwd PE | 21.66 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CBHD.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.74 | ||
| EV/EBITDA | 15.39 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBHD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CBHD's earnings are expected to grow with 21.25% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y27.16%
EPS Next 3Y21.25%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.08%, CBHD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.13, CBHD pays a better dividend. On top of this CBHD pays more dividend than 97.06% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, CBHD pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.08% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CBHD pays out 136.36% of its income as dividend. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.36%
EPS Next 2Y27.16%
EPS Next 3Y21.25%
FRA:CBHD (1/9/2026, 7:00:00 PM)
75.56
+0.1 (+0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners28.86%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap15.88B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70.4
Price Target91.92 (21.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.08% |
Yearly Dividend2.94
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.74%
PT rev (3m)-2.74%
EPS NQ rev (1m)-4.12%
EPS NQ rev (3m)12.82%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.3%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)9%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.75 | ||
| Fwd PE | 21.66 | ||
| P/S | 4.26 | ||
| P/FCF | 22.74 | ||
| P/OCF | 17.86 | ||
| P/B | 7.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.39 |
EPS(TTM)2.38
EY3.15%
EPS(NY)3.49
Fwd EY4.62%
FCF(TTM)3.32
FCFY4.4%
OCF(TTM)4.23
OCFY5.6%
SpS17.75
BVpS10.26
TBVpS-8.72
PEG (NY)0.68
PEG (5Y)N/A
Graham Number23.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.92 |
F-Score6
WACC5.55%
ROIC/WACC2.28
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y46.79%
EPS Next 2Y27.16%
EPS Next 3Y21.25%
EPS Next 5Y16.23%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.49%
EBIT Next 3Y14.67%
EBIT Next 5Y11.91%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CBHD.DE.
Can you provide the valuation status for COLOPLAST-B?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
How financially healthy is COLOPLAST-B?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.79% in the next year.